EDESA BIOTECH, INC. Investing Cash Flow
EDESA BIOTECH, INC. (EDSA) reported Investing Cash Flow of $0 for the 3-month period ending 2023-12-31, per its 10-Q filed 2024-02-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2024-02-09
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities for the quarter ending 2023-12-31 was $0.00.
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities for the quarter ending 2023-06-30 was $0.00.
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities for the quarter ending 2023-03-31 was $0.00.
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities for fiscal 2023 was $0.00.
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$5.66K.
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities for fiscal 2021 was -$6.15K, a 132.22% decline from fiscal 2020.
- EDESA BIOTECH, INC. net cash provided by (used in) investing activities for fiscal 2020 was $19.07K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 10-Q · filed 2024-02-09 | $0.00 derived: sum of 2 quarters · filed 2024-02-09 | $0.00 derived: sum of 3 quarters · filed 2024-02-09 | $0.00 derived: sum of 4 quarters · filed 2024-02-09 | ||
| 2023-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | $0.00 derived: sum of 2 quarters · filed 2023-12-15 | $0.00 derived: sum of 3 quarters · filed 2023-12-15 | $0.00 10-K · filed 2023-12-15 | ||
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-09 | $0.00 derived: sum of 2 quarters · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $41.00 derived: sum of 4 quarters · filed 2024-02-09 | ||
| 2023-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-11 | $0.00 10-Q · filed 2023-05-11 | $41.00 derived: sum of 3 quarters · filed 2024-02-09 | -$1.32K derived: sum of 4 quarters · filed 2024-02-09 | ||
| 2022-12-31 | $0.00 10-Q · filed 2024-02-09 | $41.00 derived: sum of 2 quarters · filed 2024-02-09 | -$1.32K derived: sum of 3 quarters · filed 2024-02-09 | -$2.52K derived: sum of 4 quarters · filed 2024-02-09 | ||
| 2022-09-30 | $41.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | -$1.32K derived: sum of 2 quarters · filed 2023-12-15 | -$2.52K derived: sum of 3 quarters · filed 2023-12-15 | -$5.66K 10-K · filed 2023-12-15 | ||
| 2022-06-30 | -$1.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-09 | -$2.56K derived: sum of 2 quarters · filed 2023-08-09 | -$5.70K 10-Q · filed 2023-08-09 | -$4.23K derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | -$1.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-11 | -$4.34K 10-Q · filed 2023-05-11 | -$2.88K derived: sum of 3 quarters · filed 2023-05-11 | -$6.39K derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$3.14K 10-Q · filed 2023-02-10 | -$1.68K derived: sum of 2 quarters · filed 2023-02-10 | -$5.19K derived: sum of 3 quarters · filed 2023-02-10 | -$8.15K derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-09-30 | $1.46K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-16 | -$2.05K derived: sum of 2 quarters · filed 2022-12-16 | -$5.01K derived: sum of 3 quarters · filed 2022-12-16 | -$6.15K 10-K · filed 2022-12-16 | ||
| 2021-06-30 | -$3.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-12 | -$6.47K derived: sum of 2 quarters · filed 2022-08-12 | -$7.61K 10-Q · filed 2022-08-12 | -$4.07K derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | -$2.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | -$4.10K 10-Q · filed 2022-05-13 | -$557.00 derived: sum of 3 quarters · filed 2022-05-13 | -$27.38K derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | -$1.14K 10-Q · filed 2022-02-14 | $2.41K derived: sum of 2 quarters · filed 2022-02-14 | -$24.42K derived: sum of 3 quarters · filed 2022-02-14 | $495.23K derived: sum of 4 quarters · filed 2022-02-14 | ||
| 2020-09-30 | $3.54K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-28 | -$23.29K derived: sum of 2 quarters · filed 2021-12-28 | $496.37K derived: sum of 3 quarters · filed 2021-12-28 | $19.07K 10-K · filed 2021-12-28 | ||
| 2020-06-30 | -$26.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $492.82K derived: sum of 2 quarters · filed 2021-08-13 | $15.53K 10-Q · filed 2021-08-13 | $28.29K derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | $519.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-14 | $42.36K 10-Q · filed 2021-05-14 | $55.12K derived: sum of 3 quarters · filed 2021-05-14 | $6.46M derived: sum of 4 quarters · filed 2021-05-14 | ||
| 2019-12-31 | -$477.29K 10-Q · filed 2021-02-16 | -$464.53K derived: sum of 2 quarters · filed 2021-02-16 | $5.94M derived: sum of 3 quarters · filed 2021-02-16 | $5.94M derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2019-09-30 | $12.76K derived: 10-K 9 month − 10-Q 6 month · filed 2020-12-07 | $6.42M derived: sum of 2 quarters · filed 2020-12-07 | $6.42M 10-K · filed 2020-12-07 | $6.42M derived: sum of 4 quarters · filed 2020-12-07 | ||
| 2019-06-30 | $6.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-12 | $6.41M 10-Q · filed 2019-08-14 | $6.41M 10-Q · filed 2020-08-12 | $5.77M derived: sum of 4 quarters · filed 2020-08-12 | ||
| 2019-03-31 | -$1.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-15 | -$1.50K 10-Q · filed 2020-05-15 | $6.01M 10-Q · filed 2019-05-08 | -$637.39K derived: sum of 3 quarters · filed 2020-05-15 | -$5.76M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $0.00 10-Q · filed 2020-02-13 | $4.47M 10-Q · filed 2019-02-05 | -$635.89K derived: sum of 2 quarters · filed 2020-02-13 | -$5.76M derived: sum of 3 quarters · filed 2020-02-13 | -$6.87K 10-KT · filed 2019-12-12 | |
| 2018-09-30 | -$635.89K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | -$5.76M derived: sum of 2 quarters · filed 2018-11-30 | -$5.43M derived: sum of 3 quarters · filed 2019-05-08 | -$4.47M 10-K · filed 2018-11-30 | ||
| 2018-06-30 | -$5.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | -$6.87K 10-Q · filed 2019-08-14 | -$3.83M 10-Q · filed 2018-08-08 | -$1.93M derived: sum of 4 quarters · filed 2019-05-08 | ||
| 2018-03-31 | $327.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | $1.29M 10-Q · filed 2019-05-08 | $3.19M derived: sum of 3 quarters · filed 2019-05-08 | $3.11M derived: sum of 4 quarters · filed 2019-05-08 | ||
| 2017-12-31 | $961.06K 10-Q · filed 2019-02-05 | $2.86M derived: sum of 2 quarters · filed 2019-02-05 | $2.79M derived: sum of 3 quarters · filed 2019-02-05 | $2.74M derived: sum of 4 quarters · filed 2019-02-05 | ||
| 2017-09-30 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $1.82M derived: sum of 2 quarters · filed 2018-11-30 | $1.78M derived: sum of 3 quarters · filed 2018-11-30 | $1.69M 10-K · filed 2018-11-30 | ||
| 2017-06-30 | -$76.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | -$119.99K derived: sum of 2 quarters · filed 2018-08-08 | -$209.22K 10-Q · filed 2018-08-08 | |||
| 2017-03-31 | -$43.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-07 | -$132.45K 10-Q · filed 2018-05-07 | ||||
| 2016-12-31 | -$89.23K 10-Q · filed 2018-02-07 | |||||
| 2016-09-30 | $557.41K 10-K · filed 2017-12-01 | |||||
| 2015-09-30 | $122.47K 10-K · filed 2017-12-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |